CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial
Authors
E. Clair,
Alan BaerWan‐Fai Ng,
Ghaith Noaiseh,
Chiara Baldini,
Teresa Tarrant,
Athena Papas,
Valérie Devauchelle‐Pensec,
Handong Wang,
Wenjing Xu,
Tuyet‐Hang Pham,
Ndate Fall,
William Rees +11 authors
,
Ilias Alevizos Tip Tip